Pegasus Digital Mobility Acquisition Corp - Ordinary Shares (PGSS) 10-K 31 Mar 22 2021 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	9 Months Ended
	Dec. 31, 2021	Mar. 30, 2022	Jun. 30, 2021
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Entity File Number	001-40945
Entity Registrant Name	PEGASUS DIGITAL MOBILITY ACQUISITION CORP.
Entity Incorporation, State or Country Code	KY
Entity Tax Identification Number	98-1596591
Entity Address, Address Line One	260 Mason Street
Entity Address, City or Town	Greenwich
Entity Address State Or Province	CT
Entity Address, Postal Zip Code	06830
City Area Code	345
Local Phone Number	769-4000
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001861541
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Amendment Flag	false
Transition Report	true
Auditor Name	BDO USA, LLP
Auditor Firm ID	243
Auditor Location	McLean, Virginia
Entity Public Float			$ 0
Units, each consisting of one Class A Ordinary Share and one-half of one redeemable Warrant
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one Class A Ordinary Share and one-half of one redeemable Warrant
Trading Symbol	PGSS.U
Security Exchange Name	NYSE
Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
Document Information [Line Items]
Title of 12(b) Security	Redeemable Warrants, each exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
Trading Symbol	PGSS.WS
Security Exchange Name	NYSE
Class A ordinary shares
Document Information [Line Items]
Title of 12(b) Security	Class A Ordinary Shares, par value $0.0001 per share
Trading Symbol	PGSS
Security Exchange Name	NYSE
Entity Common Stock, Shares Outstanding		22,500,000
Class B ordinary shares
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		5,625,000

UNAUDITED CONDENSED BALANCE SHE

UNAUDITED CONDENSED BALANCE SHEET	Dec. 31, 2021USD ($)
Current assets
Cash	$ 1,031,397
Prepaid expenses	722,726
Total current assets	1,754,123
Prepaid expenses - non-current portion	50,701
Marketable securities held in Trust Account	227,262,051
Total Assets	229,066,875
Current Liabilities
Accounts payable and accrued expenses	195,419
Due to related party	42,776
Total current liabilities	238,195
Warrant Liability	11,048,250
Deferred Underwriting Commissions	7,875,000
Total liabilities	19,161,445
Shareholders' Deficit
Accumulated deficit	(17,357,184)
Total shareholders' equity	(17,356,621)
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	229,066,875
Class A ordinary shares
Current Liabilities
Class A ordinary shares subject to possible redemption, 22,500,000 shares at $10.10 redemption value	227,262,051
Class B ordinary shares
Shareholders' Deficit
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 5,625,000 shares issued and outstanding	563
Preferred Shares
Shareholders' Deficit
Preference shares, $0.0001 par value; 2,000,000 shares authorized; none issued and outstanding	$ 0

UNAUDITED CONDENSED BALANCE S_2

UNAUDITED CONDENSED BALANCE SHEET (Parenthetical)	Dec. 31, 2021$ / sharesshares
Class A ordinary shares
Common shares, par value, (per share) | $ / shares	$ 0.0001
Common shares, shares issued	22,500,000
Common shares, shares outstanding	22,500,000
Class A ordinary shares subject to redemption
Temporary equity, shares outstanding	22,500,000
Temporary Equity, Redemption Price Per Share | $ / shares	$ 10.10
Class B ordinary shares
Common shares, par value, (per share) | $ / shares	$ 0.0001
Common shares, shares authorized	20,000,000
Common shares, shares issued	5,625,000
Common shares, shares outstanding	5,625,000
Preferred Shares
Preferred stock, par value, (per share) | $ / shares	$ 0.0001
Preferred stock, shares authorized	2,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS	9 Months Ended
	Dec. 31, 2021USD ($)$ / sharesshares
Formation and operating costs	$ 708,717
Loss from operations	(708,717)
Other income (expense)
Gain on marketable securities (net), dividends and interest on cash held in Trust Account	(12,051)
Offering costs allocated to warrants	(520,432)
Unrealized gain on fair value changes of warrants	(3,570,000)
Total other income, net	3,061,619
Net income	2,352,902
Class A ordinary shares
Other income (expense)
Net income	$ 8,471,802
Earnings Per Share
weighted average shares outstanding, Basic | shares	5,324,910
Weighted average shares outstanding, diluted | shares	5,324,910
Basic net income (loss) per share | $ / shares	$ 1.59
Diluted net income (loss) per share | $ / shares	$ 1.59
Class A ordinary shares subject to redemption
Earnings Per Share
weighted average shares outstanding, Basic | shares	5,324,910
Weighted average shares outstanding, diluted | shares	5,324,910
Basic net income (loss) per share | $ / shares	$ 1.59
Diluted net income (loss) per share | $ / shares	$ 1.59
Class B ordinary shares
Other income (expense)
Net income	$ (6,118,900)
Earnings Per Share
weighted average shares outstanding, Basic | shares	5,279,783
Weighted average shares outstanding, diluted | shares	5,279,783
Basic net income (loss) per share | $ / shares	$ (1.16)
Diluted net income (loss) per share | $ / shares	$ (1.16)

UNAUDITED CONDENSED STATEMENT_2

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - 9 months ended Dec. 31, 2021 - USD ($)	Class A ordinary shares	Class A ordinary shares subject to redemptionCommon Stock	Class A ordinary shares subject to redemption	Class B ordinary sharesCommon Stock	Class B ordinary shares	Preferred SharesCommon Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Mar. 29, 2021		$ 0		$ 0		$ 0		$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Mar. 29, 2021		0		0		0
Increase (Decrease) in Stockholders' Equity
Class B ordinary shares issued to Sponsor				$ 563				24,437		25,000
Class B ordinary shares issued to sponsor (in shares)				5,625,000
Sale of Public Units through public offering net of issuance costs		$ 194,399,258
Sale of Public Units through public offering net of issuance costs (in shares)		22,500,000	22,500,000
Excess of cash received over the fair value of private placement warrants								2,632,500		2,632,500
Excess of fair value of anchor investor shares sold over the purchase price								9,784,020		9,784,020
Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers									711,750	711,750
Accretion of Class A ordinary shares to redemption amount	$ 32,862,793	$ 32,862,793					$ 32,862,793	(12,440,957)	(20,421,836)	(32,862,793)
Net income	$ 8,471,802	0		$ 0	$ (6,118,900)	$ 0		$ 0	2,352,902	2,352,902
Balance at the end at Dec. 31, 2021		$ 227,262,051		$ 563					$ (17,357,184)	$ (17,356,621)
Balance at the end (in shares) at Dec. 31, 2021		22,500,000		5,625,000

UNAUDITED CONDENSED STATEMENT O

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS	9 Months Ended
	Dec. 31, 2021USD ($)
Cash flows from Operating Activities:
Net Income	$ (2,352,902)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on marketable securities (net), dividends and interest on cash held in Trust Account	(12,051)
Offering costs allocated to warrants	(520,432)
Unrealized gain on fair value changes of warrants	(3,570,000)
Changes in operating assets and current liabilities:
Prepaid expenses	(773,427)
Due to related party	42,776
Accounts payable and accrued expenses	78,419
Net cash used in operating activities	(1,360,949)
Cash Flows from Investing Activities:
Investments in marketable securities	(227,250,000)
Net cash used in investing activities	227,250,000
Cash Flows from Financing Activities:
Proceeds from initial public offering	220,500,000
Proceeds from private placement warrants	9,750,000
Proceeds from issuance of founder shares	25,000
Proceeds from promissory note	212,710
Payment on promissory note	(212,710)
Payment of offering costs	(632,654)
Net cash provided by financing activities	229,642,346
Net change in cash	1,031,397
Cash - Beginning	0
Cash - Ending	1,031,397
Supplemental Disclosure of Non-cash Financing Activities:
Accrued offering costs	117,000
Deferred underwriting commissions	7,875,000
Settlement of Private Placement Warrants liability	$ 711,750

Organization, Business Operatio

Organization, Business Operation and Going Concern	9 Months Ended
	Dec. 31, 2021
Description of Organization and Business Operations
Description of Organization and Business Operations	Note 1 - Organization and Business Operations Pegasus Digital Mobility Acquisition Corp. (the “Company”) is a recently formed blank check company incorporated as a Cayman Islands exempted company on March 30, 2021. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses or assets (the “Business Combination”). The Company has not selected any Business Combination target. As of December 31, 2021, the Company had not commenced any operations. All activity for the period from March 30, 2021 (inception) through December 31, 2021 relates to the Company’s formation and the initial public offering (“IPO”). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of gains/losses on marketable securities (net), dividends and interest on cash held in Trust Account from the proceeds derived from the IPO. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is Pegasus Digital Mobility Sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Company’s IPO was declared effective by the SEC on October 21, 2021 (the “Effective Date”). On October 26, 2021, the Company consummated the IPO of 20,000,000 units at $10.00 per unit (a “Unit”), generating gross proceeds to the Company of $200,000,000. Each Unit consists of one Class A ordinary share and one-half Simultaneously with the consummation of the IPO, the Company consummated the sale of 9,000,000 warrants (the “Private Placement Warrants”), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds to the Company of $9,000,000. Depending on the extent to which the underwriters’ over-allotment option was exercised, the Sponsor agreed to purchase an additional 900,000 Private Placement Warrants. On November 4, 2021, the underwriters partially exercised the over-allotment option and, on November 8, 2021, purchased 2,500,000 Units, generating aggregate gross proceeds of $25,000,000. On November 8, 2021, simultaneously with the sale of the over-allotment Units, the Company consummated the private sale of an additional 750,000 Private Placement Warrants, generating gross proceeds to the Company of $750,000. For the period March 30, 2021 (inception) through December 31, 2021, transaction costs amounted to $13,124,654 consisting of $4,500,000 of underwriting discounts, $7,875,000 of deferred underwriting commissions and $749,654 of other offering costs. Offering costs associated with the sale of the warrants was $520,432 and was expensed for the period March 30, 2021 (inception) through December 31, 2021. Prior to the IPO, qualified institutional buyers or institutional accredited investors (the “Anchor Investors”) expressed to the Company an interest in purchasing Units in the IPO in exchange for the Sponsor agreeing to sell the Anchor Investors Class B ordinary shares, par value $0.0001 (“Founder Shares”). Upon close of the IPO, the Anchor Investors received 1,375,000 Founder Shares (“Anchor Shares”) from the Sponsor. The fair value of the Anchor Shares was treated as an issuance cost of the offering which was allocated to the Class A ordinary shares and Public Warrants. ​ On November 4, 2021, the Sponsor transferred an aggregate of 843,750 Class B ordinary shares to the Company’s officers and independent directors (see Note 6). On December 6, 2021, 125,000 of the Class B ordinary shares were forfeited by the Sponsor as a result of the underwriters’ partial exercise of the over-allotment option and the expiration of the over-allotment option. All shares and per-share amounts have been retroactively restated to reflect the forfeiture of the 125,000 Class B ordinary shares. ​ The initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting commissions held in the Trust Account). However, the Company will only complete such Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the "Investment Company Act"). There is no assurance that the Company will be able to complete a Business Combination successfully. ​ The Company will have until 15 months from the closing of the IPO to consummate the initial Business Combination. If the Company anticipates that it may not be able to consummate the initial Business Combination within 15 months, the Company may, by resolution of its board of directors at the option of the Sponsor, extend the period of time the Company will have to consummate an initial Business Combination up to two times, each by an additional three months (for a total of up to an additional six months from the closing of the IPO), subject to the Sponsor contributing $0.10 per unit to the Trust Account (as defined below). The Company's shareholders will not be entitled to vote on, or redeem their shares in connection with, any such extension. Pursuant to the terms of the amended and restated memorandum and articles of association, in order to extend the period of time to consummate an initial Business Combination in such a manner, the Sponsor must deposit $2,250,000 into the Trust Account on or prior to the date of the applicable deadline, for each three-month extension. The Sponsor has the option to accelerate its deposit of one or both halves of the up to $4,500,000 at any time following the closing of the IPO and prior to the consummation of the initial Business Combination with the same effect of extending the time the Company will have to consummate an initial Business Combination by three or six months, as applicable. ​ Following the closing of the IPO on October 26, 2021, $202,000,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the IPO and portion of the sale of the Private Placement Warrants was deposited into a trust account (“Trust Account”) and will be invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act that invest only in direct U.S. government treasury obligations. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds held in the Trust Account will not be released from the Trust Account until the earliest to occur of: (a) the completion of its initial Business Combination, (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (i) to modify the substance or timing of its obligation to redeem 100% of its public shares if the Company does not complete its initial Business Combination within 15 months from the closing of the IPO, which is extendable at the Sponsor’s option up to 21 months as describe above (the “Combination Period”) or (ii) with respect to any other provisions relating to shareholders’ rights or pre-initial Business Combination activity; and (c) the redemption of its public shares if the Company is unable to complete its Business Combination within the Combination Period, subject to applicable law. ​ Following the closing of the over-allotment option, on November 8, 2021, $25,250,000 ($10.10 per Unit) from the net proceeds of the sale of the over-allotment Units and a portion of the sale of the Private Placement Warrants sold simultaneously with the over-allotment Units was deposited into the Trust Account. ​ The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (1) in connection with a general meeting called to approve the Business Combination or (2) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Company will also provide its public shareholders with the opportunity to redeem all or a portion of their Class A ordinary shares upon the completion of its initial Business Combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two ​ The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity”, and subsequently accreted to redemption value. In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. ​ The initial shareholders, directors, officers and advisors have agreed to waive: (i) their redemption rights with respect to any Founder Shares and public shares held by them, as applicable, in connection with the completion of the Company’s initial Business Combination; (ii) their redemption rights with respect to any Founder Shares and public shares held by them in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any other provision relating the rights of holders of the Class A ordinary shares; and (iii) their rights to liquidating distributions from the Trust Account with respect to any Founder Shares they hold if the Company fails to complete its initial Business Combination within the Combination Period or during any extended time that the Company has to consummate a Business Combination beyond the Combination Period as a result of a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (an “Extension Period”) (although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame) and (4) vote their Founder Shares and any public shares purchased during or after the IPO in favor of the Company’s initial Business Combination. Each of the Anchor Investors has entered into an investment agreement with the Company pursuant to which they have agreed that any Founder Shares held by them are (i) not entitled to redemption rights in connection with the completion of our initial Business Combination or in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association and (ii) not entitled to liquidating distributions from the Trust Account with respect to any Founder Shares the Anchor Investor holds in the event the Company fails to complete its initial Business Combination within the Combination Period or during any Extension Period. ​ The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent auditors) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below (1) $10.10 per public share or (2) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company has not independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company and, therefore, the Sponsor may not be able to satisfy those obligations. The Company has not asked the Sponsor to reserve for such obligations ​ Liquidity and Going Concern ​ As of December 31, 2021, the Company had $1,031,397 in its operating bank account, and working capital of $1,515,928. ​ In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the current liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern through one year from the date that the financial statements were issued. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. ​ In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined below). As of December 31, 2021, there were no amounts outstanding under any Working Capital Loans. ​ COVID-19 ​ On January 30, 2020, the World Health Organization (the “WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. Management continues to evaluate the impact of the COVID-19 outbreak on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Dec. 31, 2021
Significant Accounting Policies
Significant Accounting Policies	Note 2 - Significant Accounting Policies Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”). Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, the Company is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statement, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period. Use of Estimates The preparation of financial statement in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of December 31, 2021, the Company had no cash equivalents. Investments held in Trust Account Trading securities in the Trust Account were invested in U.S. Treasury Securities and marketable securities which are reported at fair value. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. Gains and losses resulting from the change in fair value of these securities is included in gain on investment held in Trust Account. The estimated fair values of the investments held in the Trust Account are determined using available market information. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on these accounts. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC Topic 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity (deficit). The Company’s Class A ordinary shares contain certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2021, 22,500,000 Class A ordinary shares subject to possible redemption are presented as, at redemption value, as temporary equity, outside of the shareholders’ equity (deficit) section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. For the period March 30, 2021 (inception) through December 31, 2021, the Company recorded accretion of $32,862,793, $12,440,957 of which was recorded in additional paid-in capital and $20,421,836 of which was included as part of accumulated deficit. Offering Costs associated with the Initial Public Offering The Company complies with ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs-SEC Materials”, and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged against the carrying value of Class A ordinary shares or the statement of operations based on the relative value of the Class A ordinary shares and the Public Warrants to the proceeds received from the Units sold upon the completion of the IPO. Accordingly, for the period from March 30, 2021 (inception) through December 31, 2021, offering costs in the aggregate of $13,124,654 were recognized, $520,432 of which was allocated to the Public Warrants and immediately expensed, and $12,604,222 was allocated to Class A ordinary shares, reducing the carrying amount of such shares. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, other than the warrant liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature. Derivative Financial Instruments The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period. Warrants The Company accounts for the Public Warrants and Private Placement Warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC Topic 480 and ASC Topic 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC Topic 480, meet the definition of a liability pursuant to ASC Topic 480, and whether the warrants meet all of the requirements for equity classification under ASC Topic 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the shareholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statement of operations. Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s balance sheet. Net Income (Loss) per Ordinary Share The statement of operations includes a presentation of income (loss) per Class A redeemable public share and income (loss) per founder non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the public Class A redeemable shares and founder non-redeemable shares, the Company first considered the total income (loss) allocable to both sets of shares. This is calculated using the total net income (loss) less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement of the accretion to redemption value of the Class A ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. Subsequent to calculating the total income (loss) allocable to both sets of shares, the Company split the amount to be allocated using a ratio of 81% for the Class A redeemable public shares and 19% for the founder non-redeemable shares for the period March 30, 2021 (inception) through December 31, 2021, reflective of the respective participation rights. The earnings per share presented in the statement of operations is based on the following: ​ ​ ​ ​ ​ ​ For the period from ​ ​ March 30, 2021 ​ ​ (Inception) through ​ ​ December 31, 2021 Net income ​ $ 2,352,902 Accretion of temporary equity to redemption value ​ (32,862,793) Net loss including accretion of temporary equity to redemption value ​ $ (30,509,891) ​ ​ ​ ​ ​ ​ ​ ​ ​ For the period from ​ ​ March 30, 2021 ​ ​ (Inception) through ​ ​ December 31, 2021 ​ Class A Class B Basic and diluted net loss per share: ​ ​ Numerator: ​ ​ Allocation of net income (loss) including accretion of temporary equity ​ $ (24,390,991) ​ $ (6,118,900) Allocation of accretion of temporary equity to redemption value ​ 32,862,793 ​ — Allocation of net income (loss) ​ $ 8,471,802 ​ $ (6,118,900) ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ Weighted-average shares outstanding ​ 5,324,910 ​ 5,279,783 Basic and diluted net income (loss) per share ​ $ 1.59 ​ $ (1.16) ​ In connection with the underwriters’ partial exercise of their over-allotment option on November 8, 2021, 625,000 Founder Shares were no longer subject to forfeiture and the Founder Shares were retroactively adjusted. Recent Accounting Pronouncements In August 2020, FASB issued ASU 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)” to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity's own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	9 Months Ended
	Dec. 31, 2021
Initial Public Offering
Initial Public Offering	Note 3-Initial Public Offering On October 26, 2021, the Company sold 20,000,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one On November 4, 2021, the underwriters partially exercised the over-allotment option, and, on November 8, 2021, purchased 2,500,000 Units, generating aggregate gross proceeds of $25,000,000.

Private Placement

Private Placement	9 Months Ended
	Dec. 31, 2021
Private Placement
Private Placement	Note 4-Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 9,000,000 Private Placement Warrants, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.00 per warrant, or $9,000,000 in the aggregate, in a private placement. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination. The Sponsor, as well as its permitted transferees, have the option to exercise the Private Placement Warrants on a cashless basis. On November 8, 2021, simultaneously with the sale of the over-allotment Units, the Company consummated the private sale of an additional 750,000 Private Placement Warrants, generating gross proceeds to the Company of $750,000. Offering costs associated with the sale of the Private Placement Warrants was $520,432 and was expensed for the period March 30, 2021 (inception) through December 31, 2021. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company in all redemption scenarios and exercisable by the holders on the same basis as the Public Warrants. A portion of the proceeds from the Private Placement Warrants in the amount of $2,250,000 was added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the public shares (subject to the requirements of applicable law) and the Private Placement Warrants will be worthless. The Private Placement Warrants are identical to the Public Warrants, except that, so long as they are held by the Sponsor or its permitted transferees: (1) they will not be redeemable by the Company (except in certain redemption scenarios when the price per Class A ordinary share equals or exceeds $10.00 (as adjusted)); (2) they (including the Class A ordinary shares issuable upon exercise of Private Placement Warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold by the Sponsor until 30 days after the completion of the Company’s initial Business Combination; (3) they may be exercised by the holders on a cashless basis; and (4) they (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) are entitled to registration rights.

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Dec. 31, 2021
Derivative Financial Instruments
Derivative Financial Instruments	Note 5-Derivative Financial instruments Warrants On December 31, 2021, 21,000,000 warrants were outstanding (11,250,000 Public Warrants and 9,750,000 Private Placement Warrants). Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the completion of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The warrants will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination and 12 months from the closing of the IPO and will expire five years after the completion of the Company’s initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company has agreed that as soon as practicable, but in no event later than 15 business days, after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants, and the Company will use its commercially reasonable efforts to cause the same to become effective within 60 business days after the closing of the initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If any such registration statement has not been declared effective by the 60th business day following the closing of the initial Business Combination, holders of the warrants will have the right, during the period beginning on the 61st business day after the closing of the initial Business Combination and ending upon such registration statement being declared effective by the SEC, and during any other period when the Company fails to have maintained an effective registration statement covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants, to exercise such warrants on a “cashless basis.” Notwithstanding the above, if the Class A ordinary shares are, at the time of any exercise of a warrant, not listed on a national securities exchange such that they do not satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, but will use the Company’s commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. In the case of a cashless exercise, each holder would pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “fair market value” (defined below) less the exercise price of the warrants by (y) the fair market value and (B) 0.361 Class A ordinary shares per warrant. The “fair market value” as used in the preceding sentence shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of exercise is received by the warrant agent. Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 . ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the last reported sale price of the Class A ordinary shares for any 20 trading days within a 30 - trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”) equals or exceeds Redemption of w arrants when the price per Class A ordinary share equals or exceeds $10.00 ● in whole and not in part; ● at $0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares, based on the redemption date and the “fair market value” of our Class A ordinary shares (as defined above); ● if, and only if, the Reference Value (as defined above under “—Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00 ”) equals or exceeds $10.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant); and ● if the Reference Value is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants. If a tender offer, exchange or redemption offer shall have been made to and accepted by the holders of the Class A ordinary shares and upon completion of such offer, the offeror owns beneficially more than 50% of the outstanding Class A ordinary shares, the holder of the warrant shall be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant had been exercised, accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to the offer. If less than 70% of the consideration receivable by the holders of the Class A ordinary shares in the applicable event is payable in the form of common equity in the successor entity that is listed on a national securities exchange or is quoted in an established over-the-counter market, and if the holder of the warrant properly exercises the warrant within thirty The Company accounts for the Public Warrants and Private Placement Warrants as liabilities in accordance with the guidance contained in ASC Topic 815-40, “Derivatives and Hedging—Contracts in Entity’s Own Equity”. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the shareholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability. Additionally, certain adjustments to the settlement amount of the Private Placement Warrants are based on a variable that is not an input to the fair value of a “fixed-for-fixed” option as defined under ASC Topic 815-40, and thus the Private Placement Warrants are not considered indexed to the Company’s own stock and not eligible for an exception from derivative accounting.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Dec. 31, 2021
Related Party Transactions
Related Party Transactions	Note 6 - Related Party Transactions Founder Shares On April 16, 2021, the Sponsor paid $25,000 in consideration for 5,750,000 Founder Shares. Up to 750,000 Founder Shares were subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. Upon close of the IPO, the Anchor Investors received 1,375,000 Founder Shares from the Sponsor. On November 4, 2021, the Sponsor transferred an aggregate of 843,750 Class B ordinary shares to the Company’s officers and independent directors. On December 6, 2021, 125,000 of the Class B ordinary shares were forfeited by the Sponsor as a result of the underwriters’ partial exercise of the over-allotment option and the expiration of the over-allotment option. All shares and per-share amounts have been retroactively restated to reflect the forfeiture of the 125,000 Class B ordinary shares. Promissory Note-Related Party On April 16, 2021, the Sponsor agreed to loan the Company up to $300,000 under an unsecured promissory note to be used for a portion of the expenses of the IPO. The Company borrowed $212,710 under the $300,000 promissory note with its Sponsor, which was fully repaid on October 26, 2021.The loan was non-interest bearing, unsecured and was due at the earlier of April 30, 2022 and the closing of the IPO. Working Capital Loans In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes the initial Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Company’s Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of the Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant at the option of the lender. The warrants would be identical to the Private Placement Warrants issued to the Sponsor. The terms of the Working Capital Loans, if any, have not been determined and no written agreements exist with respect to the Working Capital Loans. The Company does not expect to seek loans from parties other than the Sponsor or an affiliate of the Sponsor or certain of the Company’s directors and officers as the Company does not believe third parties will be willing to loan such funds and provide a waiver against any and all rights to seek access to funds in the Company’s Trust Account. As of December 31, 2021, the Company had no borrowings under the Working Capital Loans. Administrative Services Agreement The Company entered into an Administrative Services Agreement pursuant to which it will pay an affiliate of the Sponsor a total of $14,000 per month for office space and administrative and support services. The agreement was effective upon the Company’s IPO and terminates upon completion of the initial Business Combination or its liquidation, the Company will cease paying these monthly fees. As of December 31, 2021, the Company accrued $32,139 under the Administrative Services Agreement as due to related party. The $32,138 administrative expense incurred for the period from March 30, 2021 (Inception) through December 31, 2021 has been included in formation and operating costs in the statement of operations. Payables to Related Parties The Company had a payable of $10,637 to an affiliate for amounts it paid for legal fees on behalf of the Company.

Commitments and Contingencies R

Commitments and Contingencies Registration Rights	9 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Registration Rights
Commitments and Contingencies Registration Rights	Note 7 - Commitments & Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued on conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed in connection with the IPO requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to the Class A ordinary shares). The holders of these securities will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statement filed subsequent to the Company’s completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until termination of the applicable lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statement. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the IPO to purchase up to an additional 3,000,000 units to cover over-allotments, if any. On October 26, 2021, the Company paid a cash underwriting discount of 2.0% per Unit, or $4,000,000. Additionally, the underwriters will be entitled to a deferred underwriting commission of 3.5% of the gross proceeds of the IPO totaling $7,000,000 upon the completion of the Company’s initial Business Combination. On November 4, 2021, the underwriters partially exercised the over-allotment option and, on November 8, 2021, purchased 2,500,000 Units, generating aggregate gross proceeds of $25,000,000, and the Company incurred $500,000 in cash underwriting discounts and $875,000 in deferred underwriting commissions.

Shareholders' Equity

Shareholders' Equity	9 Months Ended
	Dec. 31, 2021
Shareholders' Equity
Shareholders' Equity	Note 8 – Shareholders’ Equity (Deficit) Preference shares Class A ordinary shares outstanding Class B ordinary shares outstanding On December 6, 2021, 125,000 of the Class B ordinary shares were forfeited by the Sponsor as a result of the underwriters’ partial exercise of the over-allotment option and the expiration of the over-allotment option. As of December 31, 2021, there were 5,625,000 Class B ordinary shares issued and outstanding. The sales or transfers of the Class B ordinary shares and Private Placement Warrants to the Company’s officers and independent directors, as described above, is within the scope of ASC Topic 718, “Compensation-Stock Compensation”. Under ASC 718, stock-based compensation associated with equity classified awards is measured at fair value upon the grant date. These Private Placement Warrants, which have originally been recorded as a derivative liability, have been settled on the November 4, 2021 grant date. The settlement of the $711,750 derivative liability was recorded in accumulated deficit in the accompanying balance sheet. The Class B ordinary shares and Private Placement Warrants were effectively sold or transferred subject to a performance condition (i.e., the occurrence of a Business Combination). Compensation expense related to those is recognized only when the performance condition is probable of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation would be recognized at the date a Business Combination is considered probable in an amount equal to the number of Class B ordinary shares granted times the grant date fair value per share (unless subsequently modified) less the amount initially received for the purchase of those shares. As of December 31, 2021, the Company determined that a Business Combination is not probable and therefore, no stock-based compensation expense has been recognized. The unrecognized stock-based compensation expense as of December 31, 2021 was $6,719,250. The Class A ordinary shareholders and Class B ordinary shareholders of record are entitled to one vote for each ordinary share held on all matters to be voted on by shareholders and vote together as a single class, except as required by law; provided, that, prior to the initial Business Combination, holders of the Class B ordinary shares will have the right to appoint all of the Company’s directors and remove members of the board of directors for any reason, and holders of the Class A ordinary shares will not be entitled to vote on the appointment of directors during such time. The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the IPO and related to the closing of the initial Business Combination, the ratio at which the Class B ordinary shares will convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the issued and outstanding Class B ordinary shares agree to waive such anti-dilution adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of all ordinary shares issued and outstanding upon the completion of the IPO plus all Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities issued or deemed issued in connection with the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination. The term “equity-linked securities” refers to any debt or equity securities that are convertible, exercisable or exchangeable for our Class A ordinary shares issued in a financing transaction in connection with the initial Business Combination, including but not limited to a private placement of equity or debt.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Dec. 31, 2021
Fair Value of Financial Instruments
Fair Value of Financial Instruments	Note 9 - Fair Value of Financial Instruments The Company follows the guidance in ASC Topic 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In many cases, a valuation technique used to measure fair value includes inputs from multiple levels of the fair value hierarchy described above. The lowest level of significant input determines the placement of the entire fair value measurement in the hierarchy. The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis as of December 31, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ ​ ​ ​ Prices In ​ Other ​ Other ​ ​ ​ ​ ​ Active ​ Observable ​ Unobservable ​ ​ December 31, ​ Markets ​ Inputs ​ Inputs ​ ​ 2021 ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ Marketable Securities held in Trust Account ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ – Money Market Funds ​ $ 112,628,152 ​ $ 112,628,152 ​ ​ ​ ​ ​ ​ – US Treasuries ​ 114,633,899 ​ ​ 114,633,899 ​ — ​ — Total Assets ​ $ 227,262,051 ​ $ 227,262,051 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ Warrant liabilities – Public Warrants ​ $ 6,300,000 ​ $ 6,300,000 ​ $ — ​ $ — Warrant liabilities – Private Placement Warrants ​ 4,748,250 ​ — ​ — ​ 4,748,250 Total Liabilities ​ $ 11,048,250 ​ $ 6,300,000 ​ $ — ​ $ 4,748,250 ​ Transfers between Levels 1, 2 and 3 are recognized at the end of the reporting period. The estimated fair value of the Public Warrants transferred from a Level 3 fair value measurement to a Level 1 fair value measurement as of December 31, 2021 was $6,300,000, which was determined based on the then-trading price. The Private Placement Warrants were valued with Level 3 fair value measurement inputs as of December 31, 2021. The Public Warrants are publicly traded and as such are classified as Level 1 and no longer require a valuation. The estimated fair value of the Private Placement Warrants is determined using Level 3 inputs. Inherent in a binomial model are assumptions related to expected stock-price volatility, expected term, dividend yield and risk-free interest rate. The Company estimates the volatility of its Class A ordinary shares based on management’s understanding of the volatility associated with instruments of other similar entities. The risk-free interest rate is based on the U.S. Treasury Constant Maturity similar to the expected remaining term of the Private Placement Warrants. The expected term of the Private Placement Warrants is simulated based on management assumptions regarding the timing and likelihood of completing a Business Combination. The dividend rate is based on the historical rate, which the Company anticipates will remain at zero. The following table provides a reconciliation of changes in fair value of the beginning and ending balances for our liabilities classified as Level 3: ​ ​ ​ ​ ​ ​ Warrant Liability Fair value at March 30, 2021 (inception) ​ $ — Initial classification of Public Warrant and Private Placement Warrant liability at October 26, 2021 ​ 15,330,000 Transfer of Public Warrant liability to Level 1 ​ (6,300,000) Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers (Note 8) ​ ​ (711,750) Change in fair value ​ (3,570,000) Fair Value at December 31, 2021 ​ $ 4,748,250 ​ The following table presents information about the Company’s liabilities that are measured at fair value on a recurring basis as of December 31, 2021 and October 26, 2021 (date of IPO): ​ ​ ​ ​ ​ ​ ​ ​ ​ Inputs December 31, 2021 October 26, 2021 Exercise price ​ $ 11.50 ​ $ 11.50 ​ Stock price ​ $ 9.81 ​ $ 9.64 ​ Volatility ​ 11.0 % 13.7 % Expected term of the warrants ​ 5 years ​ 5 years ​ Risk-free rate ​ 1.23 % 1.2 % Dividend yield ​ 0.0 % 0.0 % ​

Subsequent Events

Subsequent Events	9 Months Ended
	Dec. 31, 2021
Subsequent Events
Subsequent Events	Note 10-Subsequent Events

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Dec. 31, 2021
Significant Accounting Policies
Basis of Presentation	Basis of Presentation The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”).
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, the Company is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statement, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. In addition, Section 107 of the JOBS Act also provides that an “emerging growth company” can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an “emerging growth company” can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company intends to take advantage of the benefits of this extended transition period.
Use of Estimates	Use of Estimates The preparation of financial statement in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of December 31, 2021, the Company had no cash equivalents.
Investments held in Trust Account	Investments held in Trust Account Trading securities in the Trust Account were invested in U.S. Treasury Securities and marketable securities which are reported at fair value. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. Gains and losses resulting from the change in fair value of these securities is included in gain on investment held in Trust Account. The estimated fair values of the investments held in the Trust Account are determined using available market information.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on these accounts.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance enumerated in ASC Topic 480. Ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity (deficit). The Company’s Class A ordinary shares contain certain redemption rights that are considered by the Company to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2021, 22,500,000 Class A ordinary shares subject to possible redemption are presented as, at redemption value, as temporary equity, outside of the shareholders’ equity (deficit) section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A ordinary shares to equal the redemption value at the end of each reporting period. Such changes are reflected in additional paid-in capital, or in the absence of additional paid-in capital, in accumulated deficit. For the period March 30, 2021 (inception) through December 31, 2021, the Company recorded accretion of $32,862,793, $12,440,957 of which was recorded in additional paid-in capital and $20,421,836 of which was included as part of accumulated deficit.
Offering Costs Associated with the Initial Public Offering	Offering Costs associated with the Initial Public Offering The Company complies with ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs-SEC Materials”, and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering.” Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the IPO. Offering costs are charged against the carrying value of Class A ordinary shares or the statement of operations based on the relative value of the Class A ordinary shares and the Public Warrants to the proceeds received from the Units sold upon the completion of the IPO. Accordingly, for the period from March 30, 2021 (inception) through December 31, 2021, offering costs in the aggregate of $13,124,654 were recognized, $520,432 of which was allocated to the Public Warrants and immediately expensed, and $12,604,222 was allocated to Class A ordinary shares, reducing the carrying amount of such shares.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, other than the warrant liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.
Derivative Financial Instruments	Derivative Financial Instruments The Company accounts for derivative financial instruments in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value upon issuance and remeasured at each reporting date, with changes in the fair value reported in the statement of operations. The classification of derivative financial instruments is evaluated at the end of each reporting period.
Warrants	Warrants The Company accounts for the Public Warrants and Private Placement Warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in ASC Topic 480 and ASC Topic 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC Topic 480, meet the definition of a liability pursuant to ASC Topic 480, and whether the warrants meet all of the requirements for equity classification under ASC Topic 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent reporting period while the warrants are outstanding. Because the Company does not control the occurrence of events, such as a tender offer or exchange, that may trigger cash settlement of the warrants where not all of the shareholders also receive cash, the warrants do not meet the criteria for equity treatment thereunder, as such, the warrants must be recorded as derivative liability. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statement of operations.
Income Taxes	Income Taxes Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s balance sheet.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The statement of operations includes a presentation of income (loss) per Class A redeemable public share and income (loss) per founder non-redeemable share following the two-class method of income per share. In order to determine the net income (loss) attributable to both the public Class A redeemable shares and founder non-redeemable shares, the Company first considered the total income (loss) allocable to both sets of shares. This is calculated using the total net income (loss) less any dividends paid. For purposes of calculating net income (loss) per share, any remeasurement of the accretion to redemption value of the Class A ordinary shares subject to possible redemption was considered to be dividends paid to the public shareholders. Subsequent to calculating the total income (loss) allocable to both sets of shares, the Company split the amount to be allocated using a ratio of 81% for the Class A redeemable public shares and 19% for the founder non-redeemable shares for the period March 30, 2021 (inception) through December 31, 2021, reflective of the respective participation rights. The earnings per share presented in the statement of operations is based on the following: ​ ​ ​ ​ ​ ​ For the period from ​ ​ March 30, 2021 ​ ​ (Inception) through ​ ​ December 31, 2021 Net income ​ $ 2,352,902 Accretion of temporary equity to redemption value ​ (32,862,793) Net loss including accretion of temporary equity to redemption value ​ $ (30,509,891) ​ ​ ​ ​ ​ ​ ​ ​ ​ For the period from ​ ​ March 30, 2021 ​ ​ (Inception) through ​ ​ December 31, 2021 ​ Class A Class B Basic and diluted net loss per share: ​ ​ Numerator: ​ ​ Allocation of net income (loss) including accretion of temporary equity ​ $ (24,390,991) ​ $ (6,118,900) Allocation of accretion of temporary equity to redemption value ​ 32,862,793 ​ — Allocation of net income (loss) ​ $ 8,471,802 ​ $ (6,118,900) ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ Weighted-average shares outstanding ​ 5,324,910 ​ 5,279,783 Basic and diluted net income (loss) per share ​ $ 1.59 ​ $ (1.16) ​
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, FASB issued ASU 2020-06, “Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)” to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity's own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company is currently assessing the impact, if any, that ASU 2020-06 would have on its financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Dec. 31, 2021
Significant Accounting Policies
Reconciliation of net income (loss) used in earnings per share	​ ​ ​ ​ ​ ​ For the period from ​ ​ March 30, 2021 ​ ​ (Inception) through ​ ​ December 31, 2021 Net income ​ $ 2,352,902 Accretion of temporary equity to redemption value ​ (32,862,793) Net loss including accretion of temporary equity to redemption value ​ $ (30,509,891)
Reconciliation of earnings per share	​ ​ ​ ​ ​ ​ ​ ​ ​ For the period from ​ ​ March 30, 2021 ​ ​ (Inception) through ​ ​ December 31, 2021 ​ Class A Class B Basic and diluted net loss per share: ​ ​ Numerator: ​ ​ Allocation of net income (loss) including accretion of temporary equity ​ $ (24,390,991) ​ $ (6,118,900) Allocation of accretion of temporary equity to redemption value ​ 32,862,793 ​ — Allocation of net income (loss) ​ $ 8,471,802 ​ $ (6,118,900) ​ ​ ​ ​ ​ ​ ​ Denominator: ​ ​ Weighted-average shares outstanding ​ 5,324,910 ​ 5,279,783 Basic and diluted net income (loss) per share ​ $ 1.59 ​ $ (1.16)

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Dec. 31, 2021
Fair Value of Financial Instruments
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Quoted Significant Significant ​ ​ ​ ​ ​ Prices In ​ Other ​ Other ​ ​ ​ ​ ​ Active ​ Observable ​ Unobservable ​ ​ December 31, ​ Markets ​ Inputs ​ Inputs ​ ​ 2021 ​ (Level 1) ​ (Level 2) ​ (Level 3) Assets: ​ ​ ​ ​ Marketable Securities held in Trust Account ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ – Money Market Funds ​ $ 112,628,152 ​ $ 112,628,152 ​ ​ ​ ​ ​ ​ – US Treasuries ​ 114,633,899 ​ ​ 114,633,899 ​ — ​ — Total Assets ​ $ 227,262,051 ​ $ 227,262,051 ​ $ — ​ $ — Liabilities: ​ ​ ​ ​ Warrant liabilities – Public Warrants ​ $ 6,300,000 ​ $ 6,300,000 ​ $ — ​ $ — Warrant liabilities – Private Placement Warrants ​ 4,748,250 ​ — ​ — ​ 4,748,250 Total Liabilities ​ $ 11,048,250 ​ $ 6,300,000 ​ $ — ​ $ 4,748,250
Reconciliation of Changes in Fair Value of Warrant Liability Classified as Level 3	​ ​ ​ ​ ​ ​ Warrant Liability Fair value at March 30, 2021 (inception) ​ $ — Initial classification of Public Warrant and Private Placement Warrant liability at October 26, 2021 ​ 15,330,000 Transfer of Public Warrant liability to Level 1 ​ (6,300,000) Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers (Note 8) ​ ​ (711,750) Change in fair value ​ (3,570,000) Fair Value at December 31, 2021 ​ $ 4,748,250
Schedule of Quantitative Information Regarding Level 3 Fair Value Measurement Inputs	​ ​ ​ ​ ​ ​ ​ ​ ​ Inputs December 31, 2021 October 26, 2021 Exercise price ​ $ 11.50 ​ $ 11.50 ​ Stock price ​ $ 9.81 ​ $ 9.64 ​ Volatility ​ 11.0 % 13.7 % Expected term of the warrants ​ 5 years ​ 5 years ​ Risk-free rate ​ 1.23 % 1.2 % Dividend yield ​ 0.0 % 0.0 %

Organization, Business Operat_2

Organization, Business Operation and Going Concern (Details)	Dec. 06, 2021shares	Nov. 08, 2021USD ($)$ / sharesshares	Nov. 04, 2021$ / sharesshares	Oct. 26, 2021USD ($)$ / sharesshares	Dec. 31, 2021USD ($)item$ / sharesshares
Subsidiary, Sale of Stock [Line Items]
Proceeds from private placement					$ 9,750,000
Loans from working capital					$ 0
Proceeds from IPO Deposited In Trust Account				$ 202,000,000
Per share amount contributed into trust account | $ / shares				$ 10.10
Threshold number of months to complete business combination					15 months
Threshold Number Of Months To Extend Business Combination Period					3 months
Threshold Number Of Months To Extend Business Combination Period, Maximum					6 months
Offering costs allocated to warrants					$ 520,432
Cash held outside the Trust Account					1,031,397
Aggregate purchase price					25,000
Proceeds from promissory note					$ 212,710
Condition for future business combination number of businesses minimum | item					1
Condition for future business combination, number of times to extend combination period					2
Condition for future business combination, fair value					80.00%
Condition for future business combination, ownership					50.00%
Working capital deficit					$ 1,515,928
Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Common shares, par value, (per share) | $ / shares					$ 0.0001
Class A ordinary shares subject to redemption
Subsidiary, Sale of Stock [Line Items]
Number of units sold | shares					22,500,000
Sale of Public Units through public offering net of issuance costs (in shares) | shares					22,500,000
Threshold business days for redemption of public shares				2 days
Maximum net interest to pay dissolution expenses				$ 100,000
Minimum net tangible assets on redemption of temporary equity				$ 5,000,001
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)				100.00%
Class B ordinary shares
Subsidiary, Sale of Stock [Line Items]
Unit price | $ / shares			$ 0.004
Common shares, par value, (per share) | $ / shares					$ 0.0001
Units Issued To Sponsor During Period, Shares, New Issues | shares		125,000
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Redemption of shares calculated based on business days prior to consummation of business combination (in days)		185 days
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)		100.00%
Redemption of Shares Calculated Based On Number Of Business Days Prior To Consummation Of Business Combination		185 days
Private Placement Warrants | Minimum
Subsidiary, Sale of Stock [Line Items]
Threshold number of months to complete business combination		15 months
Private Placement Warrants | Maximum
Subsidiary, Sale of Stock [Line Items]
Threshold number of months to complete business combination		21 months
Public Warrants | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares issuable per warrant | shares				1	1
Exercise price of warrants | $ / shares				$ 11.50	$ 11.50
IPO
Subsidiary, Sale of Stock [Line Items]
Transaction Costs					$ 13,124,654
Underwriting fees				$ 4,000,000	4,500,000
Deferred underwriting fee payable				$ 7,000,000	7,875,000
Other offering costs					749,654
IPO | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit | shares				1
Number of shares issuable per warrant | shares				1
Transaction Costs					$ 12,604,222
IPO | Class A ordinary shares subject to redemption
Subsidiary, Sale of Stock [Line Items]
Number of units sold | shares				20,000,000
Unit price | $ / shares				$ 10
Proceeds from issuance of units				$ 200,000,000
Number of shares in a unit | shares					1
Number of warrants in a unit | shares				0.5
Sale of Public Units through public offering net of issuance costs (in shares) | shares				20,000,000
IPO | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants in a unit | shares				0.5
Offering costs allocated to warrants					$ 520,432
Exercise price of warrants | $ / shares				$ 11.50
Over-allotment option | Class A ordinary shares subject to redemption
Subsidiary, Sale of Stock [Line Items]
Number of units sold | shares		2,500,000
Sale of Public Units through public offering net of issuance costs		$ 25,000,000
Sale of Public Units through public offering net of issuance costs (in shares) | shares		2,500,000
Underwriters option to purchase (in shares) | shares				3,000,000
Threshold Number of Days From IPO for Underwriters to Purchase Additional Units				45 days
Over-allotment option | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued | shares		750,000
Proceeds from private placement		$ 750,000
Proceeds from IPO Deposited In Trust Account		$ 25,250,000
Per share amount contributed into trust account | $ / shares		$ 10.10
Sponsor
Subsidiary, Sale of Stock [Line Items]
Amount to be deposited into trust account per business combination extension					2,250,000
Maximum Amount To Be Deposited Into Trust Account For Extending Time Period					$ 4,500,000
Per share amount contributed into trust account | $ / shares					$ 0.10
Threshold Share Price For Sponsor Liability To Company | $ / shares				$ 10.10
Sponsor | Class B ordinary shares
Subsidiary, Sale of Stock [Line Items]
Units transferred By Sponsor To Company During Period, Shares | shares			843,750
Units Forfeited By Sponsor During Period, Shares | shares	125,000
Sponsor | Private Placement Warrants | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued | shares				9,000,000
Price of warrant | $ / shares				$ 1
Number of shares issuable per warrant | shares				1
Proceeds from private placement				$ 9,000,000
Warrants Subscribed but Unissued | shares				900,000
Exercise price of warrants | $ / shares				$ 11.50
Anchor Investors | Class B ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of units sold | shares				1,375,000
Common shares, par value, (per share) | $ / shares				$ 0.0001
Sale of Public Units through public offering net of issuance costs (in shares) | shares				1,375,000

Significant Accounting Polici_4

Significant Accounting Policies (Details) - USD ($)	Nov. 08, 2021	Oct. 26, 2021	Dec. 31, 2021	Mar. 31, 2021
Financing Receivable, Impaired [Line Items]
Cash			$ 1,031,397
Cash equivalents			$ 0
Maximum maturity of securities held in trust account			185 days
Offering costs allocated to warrants			$ 520,432
Unrecognized tax benefits			0	$ 0
Unrecognized tax benefits accrued for interest and penalties			0	$ 0
Net income			2,352,902
Accretion of Class A ordinary shares to redemption amount			(32,862,793)
Net Income (Loss) including accretion of temporary equity to redemption value			(30,509,891)
Common Stock
Financing Receivable, Impaired [Line Items]
Accretion of Class A ordinary shares to redemption amount			32,862,793
Additional Paid-in Capital
Financing Receivable, Impaired [Line Items]
Net income			0
Accretion of Class A ordinary shares to redemption amount			(12,440,957)
Accumulated Deficit
Financing Receivable, Impaired [Line Items]
Net income			2,352,902
Accretion of Class A ordinary shares to redemption amount			(20,421,836)
IPO
Financing Receivable, Impaired [Line Items]
Transaction Costs			13,124,654
Public Warrants | IPO
Financing Receivable, Impaired [Line Items]
Offering costs allocated to warrants			520,432
Class A ordinary shares
Financing Receivable, Impaired [Line Items]
Net income			8,471,802
Accretion of Class A ordinary shares to redemption amount			32,862,793
Net Income (Loss) including accretion of temporary equity to redemption value			$ (24,390,991)
Percentage of net income (loss) allocated to share classes			81.00%
weighted average shares outstanding, Basic			5,324,910
Weighted average shares outstanding, diluted			5,324,910
Basic net income (loss) per share			$ 1.59
Diluted net income (loss) per share			$ 1.59
Class A ordinary shares | IPO
Financing Receivable, Impaired [Line Items]
Transaction Costs			$ 12,604,222
Class A ordinary shares subject to redemption
Financing Receivable, Impaired [Line Items]
Sale of Public Units through public offering net of issuance costs (in shares)			22,500,000
weighted average shares outstanding, Basic			5,324,910
Weighted average shares outstanding, diluted			5,324,910
Basic net income (loss) per share			$ 1.59
Diluted net income (loss) per share			$ 1.59
Class A ordinary shares subject to redemption | Common Stock
Financing Receivable, Impaired [Line Items]
Sale of Public Units through public offering net of issuance costs (in shares)			22,500,000
Net income			$ 0
Accretion of Class A ordinary shares to redemption amount			32,862,793
Class A ordinary shares subject to redemption | IPO
Financing Receivable, Impaired [Line Items]
Sale of Public Units through public offering net of issuance costs (in shares)		20,000,000
Class A ordinary shares subject to redemption | Over-allotment option
Financing Receivable, Impaired [Line Items]
Sale of Public Units through public offering net of issuance costs (in shares)	2,500,000
Class B ordinary shares
Financing Receivable, Impaired [Line Items]
Shares subject to forfeiture		750,000
Net income			(6,118,900)
Net Income (Loss) including accretion of temporary equity to redemption value			$ (6,118,900)
Percentage of net income (loss) allocated to share classes			19.00%
weighted average shares outstanding, Basic			5,279,783
Weighted average shares outstanding, diluted			5,279,783
Basic net income (loss) per share			$ (1.16)
Diluted net income (loss) per share			$ (1.16)
Units Issued To Sponsor During Period, Shares, New Issues	125,000
Class B ordinary shares | Common Stock
Financing Receivable, Impaired [Line Items]
Net income			$ 0
Preferred Shares | Common Stock
Financing Receivable, Impaired [Line Items]
Net income			$ 0
Founder Shares | Class B ordinary shares
Financing Receivable, Impaired [Line Items]
Units Issued To Sponsor During Period, Shares, New Issues	625,000

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)	Nov. 08, 2021	Oct. 26, 2021	Dec. 31, 2021
Class A ordinary shares subject to redemption
Subsidiary, Sale of Stock [Line Items]
Number of units sold			22,500,000
Sale of Public Units through public offering net of issuance costs (in shares)			22,500,000
Public Warrants | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares issuable per warrant		1	1
Exercise price of warrants		$ 11.50	$ 11.50
IPO | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares in a unit		1
Number of shares issuable per warrant		1
IPO | Class A ordinary shares subject to redemption
Subsidiary, Sale of Stock [Line Items]
Number of units sold		20,000,000
Purchase price, per unit		$ 10
Number of shares in a unit			1
Number of warrants in a unit		0.5
Sale of Public Units through public offering net of issuance costs (in shares)		20,000,000
Proceeds from issuance initial public offering		$ 200,000,000
IPO | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants in a unit		0.5
Exercise price of warrants		$ 11.50
Over-allotment option | Class A ordinary shares subject to redemption
Subsidiary, Sale of Stock [Line Items]
Number of units sold	2,500,000
Sale of Public Units through public offering net of issuance costs	$ 25,000,000
Sale of Public Units through public offering net of issuance costs (in shares)	2,500,000

Private Placement (Details)

Private Placement (Details) - USD ($)	Nov. 08, 2021	Oct. 26, 2021	Dec. 31, 2021
Subsidiary, Sale of Stock [Line Items]
Proceeds from private placement			$ 9,750,000
Offering costs allocated to warrants			520,432
Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Proceeds from Issuance of Warrants Deposited In Trust			$ 2,250,000
Public Warrants
Subsidiary, Sale of Stock [Line Items]
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination			30 days
Public Warrants | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares per warrant		1	1
Exercise price of warrant		$ 11.50	$ 11.50
IPO | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of shares per warrant		1
IPO | Public Warrants
Subsidiary, Sale of Stock [Line Items]
Exercise price of warrant		$ 11.50
Offering costs allocated to warrants			$ 520,432
Over-allotment option | Private Placement Warrants
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued	750,000
Proceeds from private placement	$ 750,000
Sponsor | Private Placement Warrants | Class A ordinary shares
Subsidiary, Sale of Stock [Line Items]
Number of warrants issued		9,000,000
Number of shares per warrant		1
Exercise price of warrant		$ 11.50
Price of warrants		$ 1
Proceeds from private placement		$ 9,000,000
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination			30 days
Threshold share price of Class A shares to redeem warrants			$ 10

Derivative Financial Instrume_2

Derivative Financial Instruments (Details)	9 Months Ended
	Dec. 31, 2021item$ / sharesshares	Oct. 26, 2021$ / sharesshares
Class of Warrant or Right [Line Items]
Warrants outstanding | shares	21,000,000
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding | shares	9,750,000
Public Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding | shares	11,250,000
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months
Public Warrants expiration term	5 years
Maximum period after business combination in which to file registration statement	15 days
Period of time within which registration statement is expected to become effective	60 days
Number of trading days on which fair market value of shares is reported | item	10
Public Warrants | Class A ordinary shares
Class of Warrant or Right [Line Items]
Number of shares issuable per warrant | shares	1	1
Exercise price of warrants	$ 11.50	$ 11.50
Percentage of gross proceeds on total equity proceeds	60.00%
Threshold trading days determining volume weighted average price	20 days
Threshold Share Price To Trigger Warrant Price Adjustment	$ 9.20
Warrant exercise price adjustment multiple	0.361
Threshold consecutive trading days for redemption of public warrants	30 days
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%
Percentage on outstanding shares of holders upon completion of offer	50.00%
Threshold of consideration received in the form of common equity of target company	70.00%
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Threshold consecutive trading days for redemption of public warrants	30 days
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	180.00%
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of public warrants	30 days
Threshold trading days for redemption of public warrants	20 days
Public Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 10
Redemption price per public warrant (in dollars per share)	$ 0.10
Minimum threshold written notice period for redemption of public warrants	30 days

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Dec. 06, 2021	Nov. 08, 2021	Nov. 04, 2021	Oct. 26, 2021	Apr. 16, 2021	Dec. 31, 2021
Related Party Transaction [Line Items]
Class B ordinary shares issued to Sponsor						$ 25,000
Class B ordinary shares
Related Party Transaction [Line Items]
Shares subject to forfeiture				750,000
Units Issued To Sponsor During Period, Shares, New Issues		125,000
Sponsor | Class B ordinary shares
Related Party Transaction [Line Items]
Units transferred By Sponsor To Company During Period, Shares			843,750
Units Forfeited By Sponsor During Period, Shares	125,000
Anchor Investors | Class B ordinary shares
Related Party Transaction [Line Items]
Sale of Public Units through public offering net of issuance costs (in shares)				1,375,000
Founder Shares | Class B ordinary shares
Related Party Transaction [Line Items]
Units Issued To Sponsor During Period, Shares, New Issues		625,000
Founder Shares | Sponsor | Class B ordinary shares
Related Party Transaction [Line Items]
Consideration received					$ 25,000
Class B ordinary shares issued to sponsor (in shares)					5,750,000
Shares subject to forfeiture					750,000

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	2 Months Ended	9 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Apr. 16, 2021	Mar. 31, 2021
Related Party Transaction [Line Items]
Proceeds from promissory note		$ 212,710
Repayment of promissory note - related party		212,710
Due to related party	$ 42,776	42,776
Administrative expenses included in formation costs		32,138
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note			$ 300,000
Proceeds from promissory note		212,710
Related Party Loans
Related Party Transaction [Line Items]
Due to related party	10,637	10,637
Related Party Loans | Working capital loans warrant
Related Party Transaction [Line Items]
Outstanding balance of related party note	0	0		$ 0
Loan conversion agreement warrant	$ 1,500,000	$ 1,500,000
Price of warrant	$ 1	$ 1
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month	$ 14,000
Due to related party	$ 32,139	$ 32,139

Commitments and Contingencies_2

Commitments and Contingencies Registration Rights (Details)	Nov. 08, 2021USD ($)shares	Oct. 26, 2021USD ($)shares	Dec. 31, 2021USD ($)itemshares
Loss Contingencies [Line Items]
Maximum number of demands for registration of securities | item			3
Class A ordinary shares subject to redemption
Loss Contingencies [Line Items]
Sale of Public Units through public offering net of issuance costs (in shares) | shares			22,500,000
IPO
Loss Contingencies [Line Items]
Percentage of cash underwriting discount		2.00%
Cash underwriting discount		$ 4,000,000	$ 4,500,000
Percentage of deferred underwriting commission		3.50%
Deferred underwriting commission		$ 7,000,000	$ 7,875,000
IPO | Class A ordinary shares subject to redemption
Loss Contingencies [Line Items]
Sale of Public Units through public offering net of issuance costs (in shares) | shares		20,000,000
Proceeds from issuance initial public offering		$ 200,000,000
Over Allotment
Loss Contingencies [Line Items]
Cash underwriting discount	$ 500,000
Deferred underwriting commission	$ 875,000
Over Allotment | Class A ordinary shares subject to redemption
Loss Contingencies [Line Items]
Threshold Number of Days From IPO for Underwriters to Purchase Additional Units		45 days
Sale of Public Units through public offering net of issuance costs (in shares) | shares	2,500,000
Sale of Public Units through public offering net of issuance costs	$ 25,000,000
Underwriters option to purchase (in shares) | shares		3,000,000

Shareholders' Equity (Details)

Shareholders' Equity (Details)	Dec. 06, 2021shares	Nov. 04, 2021USD ($)$ / sharesshares	Oct. 26, 2021$ / sharesshares	Mar. 31, 2021shares	Dec. 31, 2021Vote$ / sharesshares	Dec. 31, 2021USD ($)Vote$ / sharesshares	Sep. 30, 2021shares
Class of Stock [Line Items]
Percentage of ownership, initial shareholders			20.00%
Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers | $						$ 711,750
Unrecognized stock-based compensation expense | $						$ 6,719,250
Ratio to be applied to the stock in a conversion				20	20
Private Placement Warrants
Class of Stock [Line Items]
Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers | $		$ 711,750
Private Placement Warrants | Sponsor
Class of Stock [Line Items]
Warrants transferred By Sponsor To Company During Period, Shares		975,000
Class A ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)							200,000,000
Common shares, par value, (per share) | $ / shares					$ 0.0001	$ 0.0001
Common shares, shares issued (in shares)				22,500,000	22,500,000	22,500,000
Common shares, shares outstanding (in shares)					22,500,000	22,500,000
Common shares, votes per share					1	1
Class A ordinary shares subject to redemption
Class of Stock [Line Items]
Temporary equity, shares outstanding					22,500,000	22,500,000
Sale of Public Units through public offering net of issuance costs (in shares)						22,500,000
Class B ordinary shares
Class of Stock [Line Items]
Common shares, shares authorized (in shares)				20,000,000	20,000,000	20,000,000
Common shares, par value, (per share) | $ / shares					$ 0.0001	$ 0.0001
Common shares, shares issued (in shares)			5,750,000		5,625,000	5,625,000
Common shares, shares outstanding (in shares)			5,750,000		5,625,000	5,625,000
Shares subject to forfeiture			750,000
Unit price | $ / shares		$ 0.004
Common shares, votes per share | Vote					1	1
Number of Class A common stock issued upon conversion of each share (in shares)						1
Class B ordinary shares | Sponsor
Class of Stock [Line Items]
Units transferred By Sponsor To Company During Period, Shares		843,750
Units Forfeited By Sponsor During Period, Shares	125,000
Class B ordinary shares | Anchor Investors
Class of Stock [Line Items]
Common shares, par value, (per share) | $ / shares			$ 0.0001
Sale of Public Units through public offering net of issuance costs (in shares)			1,375,000
Preferred Shares
Class of Stock [Line Items]
Preferred shares, shares authorized				2,000,000	2,000,000	2,000,000
Preferred stock, par value, (per share) | $ / shares					$ 0.0001	$ 0.0001
Preferred shares, shares issued					0	0
Preferred shares, shares outstanding				0	0	0

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($)	Nov. 04, 2021	Dec. 31, 2021
Assets:
Cash held in the Trust Account		$ 1,031,397
Marketable securities held in Trust Account		227,262,051
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability		11,048,250
Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers		711,750
Unrealized gain on fair value changes of warrants		3,570,000
Private Placement Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability		4,748,250
Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers	$ 711,750
Public Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability		6,300,000
Money Market Funds [Member]
Assets:
Marketable securities held in Trust Account		112,628,152
U.S. Treasury Securities
Assets:
Marketable securities held in Trust Account		114,633,899
Level 1
Assets:
Marketable securities held in Trust Account		227,262,051
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability		6,300,000
Level 1 | Public Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability		6,300,000
Level 1 | Money Market Funds [Member]
Assets:
Marketable securities held in Trust Account		112,628,152
Level 1 | U.S. Treasury Securities
Assets:
Marketable securities held in Trust Account		114,633,899
Level 3
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability		4,748,250
Initial classification of Public Warrant and Private Placement Warrant liability at October 26, 2021		15,330,000
Public Warrants Transfer to Level 1		(6,300,000)
Settlement of Private Placement Warrant liabilities due to the transfer of these warrants to directors and officers		(711,750)
Unrealized gain on fair value changes of warrants		(3,570,000)
Level 3 | Private Placement Warrants
Liabilities, Fair Value Disclosure [Abstract]
Warrant Liability		$ 4,748,250

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Level 3 Measurements Inputs (Details) - $ / shares	Oct. 26, 2021	Dec. 31, 2021
Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Measurements, Share Price	$ 11.50	$ 11.50
Share price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Measurements, Share Price	$ 9.64	$ 9.81
Volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Measurement, Rate	13.70%	11.00%
Expected term of the warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Measurement, Term	5 years	5 years
Risk-free rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Measurement, Rate	1.20%	1.23%
Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Measurement, Rate	0.00%	0.00%